Sensory Reconstruction of Finger Pulp Defect Using a Dorsal Digital Island Flap
Launched by THE SECOND HOSPITAL OF TANGSHAN · Dec 5, 2011
Trial Information
Current as of May 04, 2025
Completed
Keywords
ClinConnect Summary
From February 2008 to May 2009, the flap harvested from the dorsum of the middle phalanx of the same finger was used in 12 fingers in 12 patients. The flaps ranged in size from 2.0 × 2.0 cm to 2.8 × 2.2 cm. The mean pedicle length was 1.2 cm. Neurorrhaphy between the dorsal branches of the PDN and PDN was performed in both sides in all cases. Sensibility of the reconstructed finger pulp was evaluated by static 2-point discrimination (2PD) and Semmes-Weinstein monofilament test. The range of motion of the donor fingers was measured. The data were compared to those of the opposite sides.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. a finger pulp defect \> 1.5 cm in length
- • 2. necessity to preserve finger length
- • 3. patients younger than 60 years .
- Exclusion Criteria:
- • 1. injury to the dorsum of the middle phalanx of the reconstructed finger that precluded its use as donor site
- • 2. injury to the course of the vascular pedicle or opposite PDA
- • 3. defects \< 1.5 cm in length.
About The Second Hospital Of Tangshan
The Second Hospital of Tangshan is a prominent medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a commitment to improving treatment outcomes, the hospital engages in a wide array of clinical trials across various specialties, leveraging its experienced medical staff and state-of-the-art facilities. As a sponsor of clinical trials, the Second Hospital of Tangshan prioritizes ethical standards and regulatory compliance, aiming to contribute valuable insights to the medical community while enhancing therapeutic options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials